Ardent Health, Inc.
ARDTHealthcareNASDAQMedical Care Facilities · Last scanned Oct 24, 2026
Scan Results
Daily timeframeArdent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The $1.73B market capitalization puts ARDT squarely in small-cap range for its industry. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings.
Market Cap
$1.73B
Beta
0.72
P/E (TTM)
22.72
P/E (Fwd)
9.78
EPS (TTM)
$0.54
EPS (Fwd)
$1.25
ROE
10.0%
ROA
3.1%
Cash
$724.5M
Total Debt
$2.27B
Free CF
$208.3M
52W Change
-19.3%
Annual Financials
Cash vs Debt
Where ARDT stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, ARDT finished 18.43% above its 150-day moving average ($10.09) and 21.57% above its 200-day moving average ($9.83). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ARDT overbought or oversold?
At the October 19, 2026 close, ARDT's RSI(14) was 78.0, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Ardent Health, Inc. carries $2.27B in total debt against $724.5M in cash reserves — debt is roughly 3.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $208.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 10.0%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $5.13B (2022) to $6.32B (2025), reflecting a 23% increase over the period.
As with any equity investment, ARDT carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Ardent Health, Inc. and its sector.